Original document(14 pages)  中文版
    The present invention relates to a new application of taurine in preparation of medicine for raising leucycyte function. Said invented taurine can be water soluble injection, suspension or emulsion liquid, and the optimum dose of taurine is 1-13 mg/kg.d. Said taurine injection can obviously increase carbon granular clearance of mouse with immunological hypofunction due to cyclophosphamide and 60 Co irradiation, can increase number of leucocytes and weight of immune organs (spleen and thymus gland), raise serum hemolysin antibody content, enhance the phagocytic function of neutral granulocyte and conversion function of splenic lymph cell.
Application Number
申请号
03139080 Application Date
申请日
2003.09.29
Title 名称 Use of tauring for preparine medicine enhancing leucocyte function
Publication Number
公开号
1528282 Publication Date
公开日
2004.09.15
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K31/255,A61P7/00,A61P35/00
Applicant(s) Name
申请人
Baofa Medicine Inst., Jinan Development Zone
Address 地址 250100
Inventor(s) Name 发明人
Attorney & Agent 代理人 li guicun

  
Non-injection pharmaceutical product containing novel houttuynine sodium bisulfite
Herba seu flos rorippae extract drop pill and preparing method thereof
Heat-resistant lyophilized protectant of lyophilized vaccine for henpox and preparing process thereof
Soybean aglycone drop pill and preparing method thereof
Herba lysionoti extract drop pill and preparing method thereof
Hypericum japonicum total flavone powder injection and preparing method thereof
Complex rheum officinale-radix scutellariae extract injecta for treating acute pancreatitis and preparing method thereof
Andrographolide soft capsule and preparing method thereof
Lovastatin drop pill and preparing method thereof
Simvastatin drop pill and preparing method thereof
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.